agos COVID-19 Black Seed Oil Trial (LACBSOT)
Phase 3
- Conditions
- COVID-19
- Registration Number
- PACTR202007611764617
- Lead Sponsor
- agos State Government
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Individuals who have been tested and confirmed to be positive
Stable, not on ventilator
Not having any underlining ailment
males or females above 18 years.
Exclusion Criteria
Individuals already tested negative
Known allergy to black seed oil,
Those that have had treatment with any drugs or any other medicine in the last 2 weeks,
Those who refused to give informed consent,
Those with hypertension, pregnancy, breastfeeding, diabetes, asthma, hepatitis, or any other ailments
Those participating in other studies at the Centre.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Viral load at 15 day. <br>2. Length of stay in the hospital
- Secondary Outcome Measures
Name Time Method The level of inflammatory factors IL-1, IL-2, IL-6, IL-7, IL-10, granulocyte colony-stimulating factor (GCSF), interferon-gamma-induced protein (IP-10) and monocyte chemoattractant protein-1 (MCP-1) <br><br><br>